Table 2.

Univariable associations and multivariable logistic regression models of fear of recurrence among AYA (15–39 years at diagnosis) and older adult (40+ years at diagnosis) cancer survivors.

	Univariable Models % Fear of Recurrence				Multivariable modelsa
	AYA (n=1395)		Older adult (n=2497)		AYA (n=1034)b	Older adult (n=1324)b
Variables	%	p-value	%	p-value	OR (95% CI)	OR (95% CI)
Sociodemographics
Age at survey completion (mean)	37.8	<0.01	55.1	<0.001	0.967 (0.942–0.993)	0.995 (0.951–1.041)
Gender
Male	80.5		74.8		REF	REF
Female	88.4	<0.001	82.3	<0.001	1.918 (1.208–3.048)	1.192 (0.869–1.636)
Race
White	85.5		80.1			1.567 (0.907–2.708)
Other	82.5	0.31	74.1	0.06		REF
Marital Status
Married/domestic partner	86.0		81.0		1.236 (0.840–1.819)	1.109 (0.794–1.548)
Other	83.6	0.23	76.3	0.01	REF	REF
Educational attainment
Less than high school/high school degree	85.3		83.3
Some college/technical/associate’s degree	84.1		80.4
Bachelor’s degree	84.6		78.9
Graduate/medical degree	87.7	0.58	78.9	0.46
Employment status
Employed (full or part-time)	86.4		81.2		1.662 (1.080–2.558)	1.047 (0.734–1.494)
Not employed (student/caregiver/retired)	81.7	0.05	76.4	<0.01	REF	REF
Total household income
≤80,000	84.6		79.4
≥81,000	85.3	0.75	80.8	0.46
Insurance status
Private/military	85.8		81.9			REF
Medicare/Medicaid	80.7		69.8			0.597 (0.368–0.969)
Other/none/don’t know	85.5	0.58	82.8	<0.001		1.315 (0.694–2.493)
Cancer history
Age at cancer diagnosis (mean)	30.1	0.02	50.7	<0.001	1.013 (0.978–1.049)	0.993 (0.949–1.040)
Type of cancer
Breast	91.7		79.7		REF
Lymphoma	85.6		82.7		0.709 (0.285–1.760)
Melanoma	89.5		87.7		0.787 (0.254–2.433)
Testicular	82.1		74.6		0.548 (0.217–1.384)
Thyroid	83.9		83.3		0.303 (0.110–0.838)
Other	83.5	0.05	79.0	0.36	0.481 (0.217–1.066)
Time since last treatment
Less than five years	89.4		81.1		REF	REF
Five+ years	79.2	<0.001	75.2	<0.01	0.515 (0.327–0.812)	0.813 (0.532–1.245)
Currently seeing an oncologist
Yes	87.6		82.1		1.166 (0.767–1.772)	1.394 (0.995–1.952)
No	81.7	<0.01	75.1	<0.001	REF	REF
Currently seeing a primary care physician
Yes	82.6		77.5		0.902 (0.594–1.368)	0.983 (0.717–1.347)
No	87.3	0.02	81.2	0.05	REF	REF
Type of treatment(s) received
Chemotherapy
Yes	85.7		81.5			0.893 (0.641–1.244)
No	84.4	0.51	77.2	<0.01		REF
Radiation
Yes	86.6		80.9		1.282 (0.876–1.877)	0.985 (0.733–1.324)
No	84.0	0.18	78.5	0.15	REF	REF
Surgery
Yes	86.6		80.9		1.352 (0.873–2.095)	1.432 (1.032–1.986)
No	81.4	0.02	75.7	<0.01	REF	REF
Participated in a clinical trial
Yes	81.3		82.4		0.595 (0.358–0.991)	1.218 (0.779–1.903)
No	85.5	0.17	78.8	0.19	REF	REF
Received post-treatment instructions
Yes	87.5		78.9
No	84.1	0.36	80.8	0.54
Received written cancer treatment summary
Yes	81.5		78.3		0.751 (0.507–1.113)
No	86.3	0.03	79.3	0.63	REF
Perceptions of cancer experience
Dedicated patient navigator on health care team
Yes	87.1		69.9			0.616 (0.352–1.076)
No	84.8	0.72	79.4	0.03		REF
Information on late-effects/risks of treatment met…
All of my needs	74.8		69.5		0.526 (0.284–0.977)	0.410 (0.207–0.811)
Many of my needs	87.4		83.1		1.022 (0.562–1.857)	0.700 (0.364–1.350)
Some of my needs	88.2		79.7		1.187 (0.633–2.227)	0.500 (0.262–0.951)
Very few to none of my needs	87.3	<0.001	87.9	<0.001	REF	REF
Patient/Provider Communication Score (mean)	10.4	0.97	10.8	<0.001		0.949 (0.901–1.000)

AYA, adolescent and young adult; OR, odds ratio; CI, confidence interval

^aAll variables significantly associated with fear of recurrence in univariable analyses at the p < 0.25 level were entered into multivariable models; shaded cells reflect variables not entered into multivariable models.

^bAYA and non-AYA sample size for multivariable analyses was reduced due to missing values on some of the variables of interest.